Pfizer Discontinues SUN 1094 Trial of Sunitinib plus Paclitaxel in - Businesswire.com
Pfizer Inc today announced the discontinuation of the SUN 1094 Phase 3 study that evaluated SUTENT ® (sunitinib malate) plus paclitaxel versus bevacizumab plus paclitaxel for the first line treatment of patients with advanced breast cancer. The
Sri Lanka: Tamil detainees kept in appalling conditions - World Socialist Web Site
Despite considerable international pressure, the Sri Lankan government is continuing to block free access for the media and aid agencies to the military-run internment camps where more than 275,000 Tamil civilians have been detained under shocking
Pfizer Discontinues SUN 1094 Trial of Sunitinib plus Paclitaxel in - Businesswire.com
Pfizer Inc today announced the discontinuation of the SUN 1094 Phase 3 study that evaluated SUTENT ® (sunitinib malate) plus paclitaxel versus bevacizumab plus paclitaxel for the first line treatment of patients with advanced breast cancer. The
Sri Lanka: Tamil detainees kept in appalling conditions - World Socialist Web Site
Despite considerable international pressure, the Sri Lankan government is continuing to block free access for the media and aid agencies to the military-run internment camps where more than 275,000 Tamil civilians have been detained under shocking